Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide - PubMed (original) (raw)
. 1996 Mar 1;156(5):1916-22.
Affiliations
- PMID: 8596044
Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide
M R Young et al. J Immunol. 1996.
Abstract
Production of high levels of granulocyte-macrophage CSF (GM-CSF) by LLC-LN7 tumors results in myelopoietic stimulation and an increase in cells having natural suppressor (NS) activity. Prior studies showed these NS cells could be isolated from the bone marrow of tumor-bearing mice with an Ab (ER-MP12) that recognized GM-progenitor cells. The present study showed these cells to also be in the spleen, lymph node, and tumor, and that treatment of tumor-bearing mice with low doses of IFN-gamma plus TNF-alpha reduced the frequency of E-MP12+ cells. Studies focused on characterizing the intratumoral ER-MP12+ cells and the mechanism by which they suppress T cell proliferation. When isolated and seeded in soft agar with CSF-containing LLC-LN7 supernatants, the ER-MP12+ cells grew into colonies, most of which contained both granulocytic and monocytic cells. Tumor-derived ER-MP12+ cells and their culture supernatants were suppressive to T cell proliferation. Among the factors produced by ER-MP12+ cells were TGF-beta, nitric oxide (NO), IL-10, and prostaglandin E2 (PGE2). However, it was TGF-beta and NO that mediated the suppression of T cell proliferation by ER-MP12+ cells. Intratumoral ER-MP12+ cells could be maintained as suppressive blastlike cells for at least 4 days in cultures containing CSFs, but adding IFN-gamma plus TNF-alpha to these cultures caused their differentiation mainly into nonsuppressive TNF-alpha-secreting monocytic cells. These results show that intratumoral ER-MP12+ cells having homology to GM-progenitor cells suppress T cell function by producing TGF-beta and NO. IFN-gamma/TNF-alpha treatment stimulates their differentiation and shift from production of TGF-beta and NO to production of TNF-alpha.
Similar articles
- Regulation of the production and function of granulocytes and monocytes.
Cannistra SA, Griffin JD. Cannistra SA, et al. Semin Hematol. 1988 Jul;25(3):173-88. Semin Hematol. 1988. PMID: 3043672 Review. - Markers of mouse macrophage development detected by monoclonal antibodies.
Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W. Leenen PJ, et al. J Immunol Methods. 1994 Sep 14;174(1-2):5-19. doi: 10.1016/0022-1759(94)90005-1. J Immunol Methods. 1994. PMID: 8083537 Review.
Cited by
- Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets.
Al-Mterin MA, Elkord E. Al-Mterin MA, et al. Explor Target Antitumor Ther. 2022;3(4):497-510. doi: 10.37349/etat.2022.00097. Epub 2022 Aug 31. Explor Target Antitumor Ther. 2022. PMID: 36081407 Free PMC article. Review. - Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.
Zanetti M, Hernandez X, Langlade-Demoyen P. Zanetti M, et al. Springer Semin Immunopathol. 2005 Jun;27(1):87-104. doi: 10.1007/s00281-004-0197-8. Epub 2005 Feb 15. Springer Semin Immunopathol. 2005. PMID: 15711953 Review. - Dual roles of myeloid-derived suppressor cells in various diseases: a review.
Nepal MR, Shah S, Kang KT. Nepal MR, et al. Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15. Arch Pharm Res. 2024. PMID: 39008186 Review. - Myeloid-derived suppressor cells in transplantation and cancer.
Ochando JC, Chen SH. Ochando JC, et al. Immunol Res. 2012 Dec;54(1-3):275-85. doi: 10.1007/s12026-012-8335-1. Immunol Res. 2012. PMID: 22535241 Free PMC article. Review. - Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.
Dilek N, Vuillefroy de Silly R, Blancho G, Vanhove B. Dilek N, et al. Front Immunol. 2012 Jul 17;3:208. doi: 10.3389/fimmu.2012.00208. eCollection 2012. Front Immunol. 2012. PMID: 22822406 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous